The US Department of Health and Human Services (HHS) has announced a flu shot is on the way for all Americans in 2019.
A vaccine is available for people aged 6 months and older, and people with pre-existing conditions.
The US has also announced a trial of a vaccine for the first time for people with chronic obstructive pulmonary disease (COPD), a respiratory disease which can be aggravated by coughing and sneezing.
The National Institutes of Health (NIH) announced a new vaccine trial on Wednesday.
In a statement, the agency said a vaccine “can reduce the risk of developing severe acute respiratory infections and improve the survival of people with COPD and chronic obstructions”.
A total of 17 million doses will be produced in the US for all healthcare providers, according to the National Institutes.
It is hoped to be distributed in early 2020.
The flu vaccine is currently the only approved flu shot in the world, with no approved vaccines available for the other nine major countries of the world.
The new vaccine is being developed by Gilead Sciences, an American company.
The vaccine is designed to help prevent the influenza pandemic and prevent serious side effects from the virus.
The company said it has had “a strong response” to the vaccine’s design and manufacturing process.
It has been approved by the Food and Drug Administration (FDA) for people who have had a flu vaccine since April 2017.
Gileads vaccine will be used to protect people with a prior infection of the virus or other conditions, including people with severe asthma or COPD.
The disease is caused by coronavirus and is spread by respiratory droplets.
The first flu vaccine was given in December 2018.
It was found to be safe and effective, although it did not protect people from the spread of influenza.
The next vaccine will cover the pandemic in the fall of 2019.